The two largest health insurers in Massachusetts are effectively telling the drug companies that they may seek a rapidly ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.

The country’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, the UK’s official system for ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Market quiet, Nifty futures subdued, Asian markets lower. Analysts predict benefits for Indian contract manufacturers from ...

I love how the GLP-1 medication subdues my appetite. It still seems miraculous to be able to say 'no' to cakes, desserts and ...

Health insurance companies, including CVS Caremark, are altering coverage for GLP-1 weight loss medications like Zepbound, ...

On Saturday, the Juice hitmaker took to Instagram to share a video of herself modeling a sexy piece of swimwear from her ...